InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-17 · accession 0001127602-21-023999 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-08-18 2021-08-17 GILD Wilfong Diane E. SVP, CAO, Ctrl M - OptEx $68.08 +13.6K 34.0K +67% +$926.5K
D 2021-08-18 2021-08-17 GILD Wilfong Diane E. SVP, CAO, Ctrl S - Sale+OE $72.50 -13.6K 20.4K -40% -$986.7K
DM 2021-08-18 2021-08-17 GILD Wilfong Diane E. SVP, CAO, Ctrl M - OptEx $0.00 -13.6K 5,869 -70% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-17 M A 9,781 $68.75 30,179 D — —
2 Common Common Stock 2021-08-17 M A 3,829 $66.36 34,008 D — —
3 Common Common Stock 2021-08-17 S D 13,610 $72.50 20,398 D — —
4 Derivative Non-qualified Stock Option (Right to Buy) 2021-08-17 M D 3,829 $0.00 0 D $66.36 · — to 2027-02-10 3,829 Common Stock (F1) The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
5 Derivative Non-qualified Stock Option (Right to Buy) 2021-08-17 M D 9,781 $0.00 5,869 D $68.75 · — to 2029-02-06 9,781 Common Stock (F1) The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.